Track topics on Twitter Track topics that are important to you
The London markets and private equity-backed IPOs', prepared for the BVCA and the London Stock Exchange by Oxera, examines certain aspects relevant to assessing the attractiveness of the London markets for private equity-backed IPOs. The report specifically looks at the proportion of private equity-backed companies that float on the London markets, their after-market
Phone: 020-7025 2950
Fax: 020-7025 2951
Audax Private Equity has partnered with management to acquire Altasciences Company, an early phase CRO in North America. Audax acquired Altasciences from Kilmer Capital Partners, a private equity firm...
Despite a turbulent healthcare environment, the industry can remain a winning investment for private equity funds that follow a few key principles.
Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.
Canada-based, US-run drugmaker Valeant has agreed to sell its iNova Pharmaceuticals subsidiary for $930 million in cash to a company jointly owned by funds advised and managed by Pacific Equity Partne...
Private equity bought more behavioral health businesses in 2016 than strategic buyers as increased insurance coverage and reforms fueled growth.
NEWPORT BEACH, Calif. ― At the OCTANe Ophthalmology Technology Summit, Richard L. Lindstrom, MD, discusses the impact that private equity will have on ophthalmology over the next 5 years.
In this second of six articles from the lawyers from Epstein Becker & Green and the analysts from Provident Healthcare Partners, LLC, Steven Grassa and Anjana D. Patel, Esq., delve into the hot sector...
A private equity firm, Calculus Capital, has invested £2.5 million in the Cambridge-based biotech company, Axol Bioscience.
The 2007-2008 global financial crisis revived interest in the impacts of financial markets and actors on our social and economic life. Nevertheless, research on health care financialisation remains sc...
Brucellosis is a zoonotic bacterial disease that causes recurring febrile illness in humans, as well as reproductive failure and reduced milk production in livestock. The cost of brucellosis is equal ...
The aim of this paper is to describe a conceptual framework for how to consider health equity in the GRADE (Grading Recommendations Assessment and Development Evidence) guideline development process.
Equity and justice in healthcare payment form an integral part of health policy and planning. In the majority of low and middle-income countries (LMICs), healthcare inequalities are further aggravated...
Private healthcare services in Vietnam are seen as a major part of the solution to the rapid increase in need and demand for healthcare services. Formally recognized over 20 years ago, the private hea...
This is the Phase 3 of a 3 phase study to determine the feasibility, acceptability and effectiveness of a health microinsurance scheme in improving health equity and clinical outcomes for ...
The IMAGE Study is a cluster randomised trial of a structural intervention for the prevention of HIV and gender based violence being conducted in South Africa.
Cost-effective management of heart failure and pulmonary disease is of paramount importance. Unfortunately, the rapid and accurate differentiation of heart failure from other causes of dys...
The purpose of this study is to assess patient and companion acceptability of medical education in a non-teaching private hospital
This one-arm, multi-centric, non-randomized, observational, open label, prospective study was designed to study short subjects born SGA, by pediatricians, endocrinologists or physicians in...
The London markets and private equity-backed IPOs', prepared for the BVCA and the London Stock Exchange by Oxera, examines certain aspects relevant to assessing the attractiveness of the London market...
AIG Private Equity Ltd. is a Swiss investment company with an objective to achieve long-term capital growth for shareholders by investing in a diversified portfolio of private equity funds and private...
NBGI Private Equity was formed to invest in established small to medium-sized "traditional economy" businesses across the UK. This sector is the backbone of the economy but, as the marketplace has mat...
International Private Equity Services Limited ("IPES") was established in early 1998 in order to meet the increasing demands of the Private Equity community. The development of new fund structures, th...
Brazos Private Equity Partners is a Dallas-based private equity firm that has managed investment funds with approximately $1.4 billion of equity capital since inception. Brazos fo...
We have published hundreds of BvcaEuropean Private Equity news stories on BioPortfolio along with dozens of BvcaEuropean Private Equity Clinical Trials and PubMed Articles about BvcaEuropean Private Equity for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BvcaEuropean Private Equity Companies in our database. You can also find out about relevant BvcaEuropean Private Equity Drugs and Medications on this site too.